Annual CFI
$4.96 M
+$5.23 M+1916.40%
30 June 2024
Summary:
Estrella Immunopharma annual cash flow from investing activities is currently $4.96 million, with the most recent change of +$5.23 million (+1916.40%) on 30 June 2024. During the last 3 years, it has risen by +$4.96 million (+100.00%). ESLA annual CFI is now at all-time high.ESLA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Estrella Immunopharma quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$5.07 million (-100.00%). ESLA quarterly CFI is now -100.00% below its all-time high of $5.07 million, reached on 31 December 2023.ESLA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$5.07 M
+$112.30 K+2.26%
30 September 2024
Summary:
Estrella Immunopharma TTM cash flow from investing activities is currently $5.07 million, with the most recent change of +$112.30 thousand (+2.26%) on 30 September 2024. Over the past year, it has increased by +$385.30 thousand (+8.22%). ESLA TTM CFI is now at all-time high.ESLA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1916.4% | -100.0% | +8.2% |
| 3 y3 years | +100.0% | 0.0% | +100.0% |
| 5 y5 years | - | - | - |
ESLA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1916.4% | -100.0% | +100.0% | at high | +1416.6% |
| 5 y | 5 years | at high | +1916.4% | -100.0% | +100.0% | at high | +1416.6% |
| alltime | all time | at high | +1916.4% | -100.0% | +100.0% | at high | +1416.6% |
Estrella Immunopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $5.07 M(+2.3%) |
| June 2024 | $4.96 M(-1916.4%) | $0.00(0.0%) | $4.96 M(+2.8%) |
| Mar 2024 | - | $0.00(-100.0%) | $4.82 M(+2.9%) |
| Dec 2023 | - | $5.07 M(-4617.3%) | $4.69 M(-1316.6%) |
| Sept 2023 | - | -$112.30 K(-17.7%) | -$385.30 K(+41.1%) |
| June 2023 | - | -$136.50 K(0.0%) | -$273.00 K(+100.0%) |
| June 2023 | -$273.10 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$136.50 K(<-9900.0%) | -$136.50 K(<-9900.0%) |
| Dec 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | $0.00(0.0%) | - | - |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | - | $0.00 | $0.00 |
| June 2021 | $0.00 | - | - |
FAQ
- What is Estrella Immunopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Estrella Immunopharma?
- What is Estrella Immunopharma annual CFI year-on-year change?
- What is Estrella Immunopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly CFI year-on-year change?
- What is Estrella Immunopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Estrella Immunopharma?
- What is Estrella Immunopharma TTM CFI year-on-year change?
What is Estrella Immunopharma annual cash flow from investing activities?
The current annual CFI of ESLA is $4.96 M
What is the all time high annual CFI for Estrella Immunopharma?
Estrella Immunopharma all-time high annual cash flow from investing activities is $4.96 M
What is Estrella Immunopharma annual CFI year-on-year change?
Over the past year, ESLA annual cash flow from investing activities has changed by +$5.23 M (+1916.40%)
What is Estrella Immunopharma quarterly cash flow from investing activities?
The current quarterly CFI of ESLA is $0.00
What is the all time high quarterly CFI for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly cash flow from investing activities is $5.07 M
What is Estrella Immunopharma quarterly CFI year-on-year change?
Over the past year, ESLA quarterly cash flow from investing activities has changed by -$5.07 M (-100.00%)
What is Estrella Immunopharma TTM cash flow from investing activities?
The current TTM CFI of ESLA is $5.07 M
What is the all time high TTM CFI for Estrella Immunopharma?
Estrella Immunopharma all-time high TTM cash flow from investing activities is $5.07 M
What is Estrella Immunopharma TTM CFI year-on-year change?
Over the past year, ESLA TTM cash flow from investing activities has changed by +$385.30 K (+8.22%)